FreeCME

18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies

/ Print /
| ShareMore
/ Text Size +
2/5/22 8:00 am to 5:00 pm EDT
InterContinental New York Barclay + Virtual Webinar



The 18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a single-day educational conference designed to examine current and emerging treatments in melanoma, basal cell carcinoma, squamous cell carcinoma, and other skin-related cancers. With insights from world-renowned experts, this engaging program will bring you up to date on the evolving standards of care in melanoma and other cutaneous malignancies.

Learning Objectives

The learning objectives of this program are:

  • Analyze the use of biomarkers in personalizing care for patients with cutaneous malignancies
  • Assess the latest clinical trials on current and emerging treatment options for melanoma and other skin-related tumors
  • Develop optimal management protocols for the treatment of melanoma, basal cell carcinoma, squamous cell carcinoma, and other cutaneous malignancies
  • Design best practices for the prevention and mitigation of treatment-associated adverse events in the management of cutaneous malignancies

Use code ISMO35CME for 35 percent off!

Target Audience

The target audience for this activity is medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will also be invited to participate.

Date

February 5, 2022
8:00 AM - 5:00 PM Eastern Time
Hybrid Interactive Conference

Program Co-Chairs

Omid Hamid, MD
Chief, Translational Research and Immuno-Oncology, The Angeles Clinic
Co-Director, Cutaneous Malignancies, Cedars Sinai Cancer
The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate

 

Jeffrey S. Weber, MD, PhD
Deputy Director and Head,
Experimental Therapeutics
Laura and Isaac Perlmutter Comprehensive Cancer Center
Professor of Medicine
NYU Grossman School of Medicine
New York, NY